osimertinib,zorifertinib,gefitinib,erlotinib
astrazeneca
['sclc', 'lung', 'osimertinib', 'nsclc']
#asco23 abs#9001
phiii study of 1l azd3759 (zorifertinib) vs. gef/erlotinib in egfrmt #nsclc w/ cns mets
1l zori better than g/e, important for the issue of #access where osimertinib is not available
oral session, lung cancer, d1 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl